Keywords: |
aged, 80 and over; survival analysis; review; cancer recurrence; fluorouracil; patient selection; risk benefit analysis; capecitabine; adjuvant therapy; chemotherapy, adjuvant; medical decision making; quality of life; kidney disease; antineoplastic combined chemotherapy protocols; colonic neoplasms; cancer research; medical assessment; age; risk assessment; patient participation; social support; folinic acid; colon cancer; comorbidity; patient compliance; liver disease; daily life activity; metastasis potential; physician attitude; elderly care; frail elderly; good clinical practice; medical ethics; patient attitude; psychological well being; health services for the aged
|